John C. Landon, Founder of BIOQUAL, Inc., Passes Away at the Age Of 84

Rhea-AI Summary

Dr. John C. Landon, former president, CEO, and chairman of the board of BIOQUAL, passed away on January 10, 2021, at age 84. A distinguished biologist, he contributed significantly to cancer research and led BIOQUAL from a small enterprise to a $20 million life sciences corporation. Under his leadership, BIOQUAL expanded its services to include pivotal roles in vaccine and therapeutic research, notably in combating COVID-19. His legacy is marked by advancements in biomedical research and his dedication to enhancing global health.

Positive

• Transformed BIOQUAL from a one-product company to a $20M+ life sciences corporation.
• Played a key role in innovative research for COVID-19 vaccines and therapeutics.
• Long career marked by significant contributions to cancer research.

Negative

• None.

Dr. John C. Landon, past president, CEO and former chairman of the board of BIOQUAL, passed away Sunday, January 10, 2021, at the age of 84. John was born and raised in Hornell, New York, and went on to earn a B.A. degree in biology from Alfred College (class of 1959) and M.S. and Ph.D. degrees in biology from The George Washington University in 1962 and 1967, respectively. John worked for most of his career in Maryland, but spent his summers in Brewster, Massachusetts, which he retired to in 2013.

John had a long and distinguished career in biology. He began his career at the National Cancer Institute working in cancer virology, then went on to join Litton Bionetics from 1965 until 1975, where he became the Science Director of the Frederick Cancer Research Center. In 1975, he became President and Director of Mason Research Institute, a subsidiary of Edgerton, Germeshausen, and Grier, Inc., now known as Perkin Elmer. In 1982, he became president of BIOQUAL, originally named Diagnon Corporation, a biomedical research corporation that provided contract services to the National Institutes of Health, as well as academic and commercial clients. He led BIOQUAL for more than 30 years as President and CEO, and was a key figure in its growth and development from a one-product company to a $20M + life sciences corporation by the time of his retirement. BIOQUAL continues to thrive today, providing innovative research support for improved global health and playing a key role in testing vaccines and therapeutics for COVID-19 and many other diseases.

www.bioqual.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20210122005361/en/

FAQ

What were Dr. John C. Landon's contributions to BIOQUAL?

Dr. John C. Landon transformed BIOQUAL into a leading life sciences corporation, overseeing its growth and expansion into innovative research areas, including COVID-19.

When did Dr. John C. Landon pass away?

Dr. John C. Landon passed away on January 10, 2021.

What was BIOQUAL's revenue under Dr. Landon's leadership?

Under Dr. Landon's leadership, BIOQUAL grew to be a corporation with revenues exceeding $20 million.

What role did BIOQUAL play in COVID-19 research?

BIOQUAL played a crucial role in testing vaccines and therapeutics for COVID-19 during Dr. Landon's tenure.

What was Dr. Landon's academic background?

Dr. Landon earned a B.A. in biology from Alfred College, followed by M.S. and Ph.D. degrees in biology from The George Washington University.